191 related articles for article (PubMed ID: 30298374)
1. Evaluation of Drug-Loaded Gold Nanoparticle Cytotoxicity as a Function of Tumor Vasculature-Induced Tissue Heterogeneity.
Miller HA; Frieboes HB
Ann Biomed Eng; 2019 Jan; 47(1):257-271. PubMed ID: 30298374
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic/Pharmacodynamics Modeling of Drug-Loaded PLGA Nanoparticles Targeting Heterogeneously Vascularized Tumor Tissue.
Miller HA; Frieboes HB
Pharm Res; 2019 Nov; 36(12):185. PubMed ID: 31773287
[TBL] [Abstract][Full Text] [Related]
3. An interdisciplinary computational/experimental approach to evaluate drug-loaded gold nanoparticle tumor cytotoxicity.
Curtis LT; England CG; Wu M; Lowengrub J; Frieboes HB
Nanomedicine (Lond); 2016 Feb; 11(3):197-216. PubMed ID: 26829163
[TBL] [Abstract][Full Text] [Related]
4. Two-dimensional chemotherapy simulations demonstrate fundamental transport and tumor response limitations involving nanoparticles.
Sinek J; Frieboes H; Zheng X; Cristini V
Biomed Microdevices; 2004 Dec; 6(4):297-309. PubMed ID: 15548877
[TBL] [Abstract][Full Text] [Related]
5. Enhanced penetration into 3D cell culture using two and three layered gold nanoparticles.
England CG; Priest T; Zhang G; Sun X; Patel DN; McNally LR; van Berkel V; Gobin AM; Frieboes HB
Int J Nanomedicine; 2013; 8():3603-17. PubMed ID: 24124360
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin-conjugated gold nanoparticles-based drug delivery system for targeting hepatic tumors.
Hassanen EI; Korany RMS; Bakeer AM
J Biochem Mol Toxicol; 2021 May; 35(5):e22722. PubMed ID: 33484050
[TBL] [Abstract][Full Text] [Related]
7. The Tumor Microenvironment as a Barrier to Cancer Nanotherapy.
Curtis LT; Frieboes HB
Adv Exp Med Biol; 2016; 936():165-190. PubMed ID: 27739048
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin-loaded gelatin-poly(acrylic acid) nanoparticles: synthesis, antitumor efficiency in vivo and penetration in tumors.
Ding D; Zhu Z; Liu Q; Wang J; Hu Y; Jiang X; Liu B
Eur J Pharm Biopharm; 2011 Sep; 79(1):142-9. PubMed ID: 21272637
[TBL] [Abstract][Full Text] [Related]
9. Ultrasmall gold nanosatellite-bearing transformable hybrid nanoparticles for deep tumor penetration.
Son S; Deepagan VG; Shin S; Ko H; Min J; Um W; Jeon J; Kwon S; Lee ES; Suh M; Lee DS; Park JH
Acta Biomater; 2018 Oct; 79():294-305. PubMed ID: 30134209
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of uptake and distribution of gold nanoparticles in solid tumors.
England CG; Gobin AM; Frieboes HB
Eur Phys J Plus; 2015 Nov; 130(11):. PubMed ID: 27014559
[TBL] [Abstract][Full Text] [Related]
11. Design and Application of Cisplatin-Loaded Magnetic Nanoparticle Clusters for Smart Chemotherapy.
Mandriota G; Di Corato R; Benedetti M; De Castro F; Fanizzi FP; Rinaldi R
ACS Appl Mater Interfaces; 2019 Jan; 11(2):1864-1875. PubMed ID: 30580523
[TBL] [Abstract][Full Text] [Related]
12. Decoding Live Cell Interactions with Multi-Nanoparticle Systems: Differential Implications for Uptake, Trafficking, and Gene Regulation.
Liang L; Liu Z; Barman I
ACS Appl Mater Interfaces; 2019 Sep; 11(37):33659-33666. PubMed ID: 31436085
[TBL] [Abstract][Full Text] [Related]
13. Multicompartment modeling of protein shedding kinetics during vascularized tumor growth.
Machiraju GB; Mallick P; Frieboes HB
Sci Rep; 2020 Oct; 10(1):16709. PubMed ID: 33028917
[TBL] [Abstract][Full Text] [Related]
14. Multifunctional Gold Nanoparticle-Based Fluorescence Resonance Energy-Transfer Probe for Target Drug Delivery and Cell Fluorescence Imaging.
Zhang Q; Gong Y; Guo XJ; Zhang P; Ding CF
ACS Appl Mater Interfaces; 2018 Oct; 10(41):34840-34848. PubMed ID: 30264982
[TBL] [Abstract][Full Text] [Related]
15. Polyaspartic acid functionalized gold nanoparticles for tumor targeted doxorubicin delivery.
Khandekar SV; Kulkarni MG; Devarajan PV
J Biomed Nanotechnol; 2014 Jan; 10(1):143-53. PubMed ID: 24724506
[TBL] [Abstract][Full Text] [Related]
16. Gold Nanoparticles as Targeted Delivery Systems and Theranostic Agents in Cancer Therapy.
Mioc A; Mioc M; Ghiulai R; Voicu M; Racoviceanu R; Trandafirescu C; Dehelean C; Coricovac D; Soica C
Curr Med Chem; 2019; 26(35):6493-6513. PubMed ID: 31057102
[TBL] [Abstract][Full Text] [Related]
17. Cyclodextrin capped gold nanoparticles as a delivery vehicle for a prodrug of cisplatin.
Shi Y; Goodisman J; Dabrowiak JC
Inorg Chem; 2013 Aug; 52(16):9418-26. PubMed ID: 23889547
[TBL] [Abstract][Full Text] [Related]
18. Improved efficacy of cisplatin in combination with a nano-formulation of pentacyclic triterpenediol.
Alam N; Qayum A; Kumar A; Khare V; Sharma PR; Andotra SS; Singh SK; Koul S; Gupta PN
Mater Sci Eng C Mater Biol Appl; 2016 Nov; 68():109-116. PubMed ID: 27524002
[TBL] [Abstract][Full Text] [Related]
19. Gold nanoparticle induced vasculature damage in radiotherapy: Comparing protons, megavoltage photons, and kilovoltage photons.
Lin Y; Paganetti H; McMahon SJ; Schuemann J
Med Phys; 2015 Oct; 42(10):5890-902. PubMed ID: 26429263
[TBL] [Abstract][Full Text] [Related]
20. Xanthan gum stabilized gold nanoparticles: characterization, biocompatibility, stability and cytotoxicity.
Pooja D; Panyaram S; Kulhari H; Rachamalla SS; Sistla R
Carbohydr Polym; 2014 Sep; 110():1-9. PubMed ID: 24906721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
